Richard D. Pilnik serves as Executive at DiaMedica Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Richard D. Pilnik has executed 14 insider transactions totaling $399.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 2, 2024 involved receiving (via award) 30,357 shares valued at $85.0K.
Richard D. Pilnik currently holds 278,602 shares of DiaMedica Therapeutics Inc. (DMAC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard D. Pilnik has been a net buyer of DMAC stock. They have purchased $399.6K and sold $0 worth of shares.
Richard D. Pilnik's most recent insider trade was on Jan 2, 2024, when they sold 30,357 shares at $2.80 per share.
Get notified when new Form 4 filings are submitted
| $3.91 |
| Discretionary |
| Jan 3, 2023 | DMAC | $85.0K | Award | 55,555 | $1.53 | Discretionary |
| Dec 5, 2022 | DMAC | $48.6K | Purchase | 35,000 | $1.39 | Discretionary |
| Jan 3, 2022 | DMAC | $85.1K | Award | 23,762 | $3.58 | Discretionary |
| Aug 16, 2021 | DMAC | $8.0K | Purchase | 2,500 | $3.21 | Discretionary |
| Aug 16, 2021 | DMAC | $41.0K | Purchase | 12,500 | $3.28 | Discretionary |
| Jan 1, 2021 | DMAC | $80.0K | Award | 9,719 | $8.23 | Discretionary |
| Dec 4, 2020 | DMAC | $27.5K | Purchase | 5,000 | $5.50 | Discretionary |
| Dec 4, 2020 | DMAC | $26.2K | Purchase | 5,000 | $5.24 | Discretionary |
| Jun 1, 2020 | DMAC | $46.7K | Award | 10,168 | $4.59 | Discretionary |
| Aug 16, 2019 | DMAC | $20.1K | Purchase | 7,840 | $2.56 | Discretionary |
| May 31, 2019 | DMAC | $53.2K | Purchase | 19,000 | $2.80 | Discretionary |
| Dec 11, 2018 | DMAC | $25.0K | Purchase | 6,250 | $4.00 | Discretionary |